Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
Holders of 5% or more of FUSN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Fusion Pharmaceuticals Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Fusion Pharmaceuticals Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Fusion Pharmaceuticals Inc., newest first.
No Schedule 13D or 13G filings on Fusion Pharmaceuticals Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Fusion Pharmaceuticals Inc. shares.
No Form 144 notices for Fusion Pharmaceuticals Inc. are on file.